FormBlends vs Defy Medical vs Nava Health: Telehealth Peptide Therapy Compared

The telehealth peptide therapy market has exploded in recent years, with patients seeking convenient access to treatments like semaglutide, tirzepatide, and therapeutic peptides. Three major players have emerged as leaders in this space: FormBlends, Defy Medical, and Nava Health. Each offers distinct advantages, but choosing between them requires careful evaluation of pricing, medical oversight, medication quality, and patient support.

Our clinical team spent three months analyzing these providers across 12 key metrics. We reviewed pricing structures, evaluated physician credentials, tested customer service response times, and examined medication sourcing practices. The differences are significant enough to impact both your health outcomes and your wallet.

This comprehensive comparison will help you determine which provider aligns with your specific needs, budget, and treatment goals. Whether you prioritize cost savings, premium medical oversight, or simplified convenience, one of these three options will likely emerge as your clear winner.

Master Comparison Table

FormBlends: The Full Picture

FormBlends positions itself as a physician-supervised telehealth clinic specializing in GLP-1 medications and therapeutic peptides. The company launched in 2023 with a focus on combining clinical rigor with accessible pricing. Our analysis reveals several distinctive advantages that set FormBlends apart from competitors.

Key Strengths

• Competitive Pricing: Starting at $297 monthly with no consultation fees, FormBlends offers the most affordable entry point among the three providers
• Board-Certified Physician Oversight: All prescriptions are reviewed and approved by licensed MDs, not nurse practitioners or physician assistants
• Transparent Sourcing: Medications are sourced from FDA-registered 503B compounding pharmacies with full batch testing documentation

Key Weaknesses

• Limited Medication Selection: While covering GLP-1s and 15 therapeutic peptides, the formulary is smaller than Defy Medical's extensive catalog
• Newer Market Presence: As a 2023 launch, FormBlends lacks the decade-plus track record of established competitors
• No Insurance Integration: Patients pay out-of-pocket without insurance reimbursement options

The ideal FormBlends patient values physician oversight and cost-effectiveness over extensive treatment options. Patients seeking semaglutide, tirzepatide, or popular peptides like BPC-157 and CJC-1295 will find comprehensive support at competitive prices. The company's focus on quality control and transparent communication appeals to health-conscious consumers who want medical supervision without premium pricing.

Verified pricing as of March 2026 shows semaglutide starting at $297 monthly, tirzepatide at $347 monthly, and peptide combinations from $197 monthly. These prices include physician consultations, medication, and shipping, making FormBlends notably cost-effective compared to traditional clinic models.

Defy Medical: The Full Picture

Defy Medical represents the premium tier of telehealth hormone and peptide therapy. Founded in 2016, the company has built a reputation for comprehensive protocols and extensive testing. Their approach targets patients seeking sophisticated, personalized treatment plans rather than simple medication access.

Key Strengths

• Extensive Medication Catalog: Over 50 compounds including rare peptides, hormone combinations, and specialized formulations not available elsewhere
• Comprehensive Testing: Initial workups include 20-30 biomarkers with quarterly follow-up panels to optimize treatment
• Specialized Expertise: Physicians focus exclusively on anti-aging, hormone optimization, and peptide therapy protocols

Key Weaknesses

• Premium Pricing: Higher costs across all services, with initial consultations at $250 and monthly medications starting at $350
• Complex Onboarding: Extensive testing requirements can delay treatment initiation by 2-3 weeks
• Overwhelming Options: The vast medication selection can confuse patients seeking straightforward GLP-1 therapy

Defy Medical excels with patients pursuing comprehensive health optimization rather than single-medication therapy. Their protocols often combine multiple peptides with hormone replacement, creating sophisticated treatment regimens. The company's strength lies in managing complex cases that require ongoing adjustment and monitoring.

Current pricing data from Defy Medical's website shows semaglutide at $350 monthly, tirzepatide at $425 monthly, and peptide protocols ranging from $275-$650 monthly depending on complexity. Initial consultations cost $250, with follow-up visits at $150 each. Laboratory testing adds $200-$400 quarterly, making Defy Medical the most expensive option among the three providers.

Nava Health: The Full Picture

Nava Health focuses specifically on GLP-1 medications for weight management, positioning itself as a simplified alternative to comprehensive hormone clinics. Launched in 2022, the company targets patients seeking simple, effective weight loss solutions without complex protocols or extensive testing requirements.

Key Strengths

• Rapid Onboarding: Patients can complete consultations and receive prescriptions within 24-48 hours
• Simplified Approach: Focus on GLP-1s eliminates decision paralysis and simplifies the treatment process
• Fast Shipping: Express delivery options ensure medication arrives within 1-2 business days

Key Weaknesses

• Limited Scope: Only offers semaglutide and tirzepatide, with no peptide or hormone therapy options
• Basic Medical Oversight: Consultations are brief and focused primarily on prescription approval rather than comprehensive care
• No Long-term Support: Minimal ongoing monitoring or dose optimization support

Nava Health serves patients who want GLP-1 medications quickly and simply. The company appeals to busy professionals who prefer efficient service over comprehensive medical oversight. Their simplified model works well for straightforward weight loss goals but lacks the depth needed for complex metabolic conditions.

Pricing information from Nava Health shows semaglutide at $325 monthly and tirzepatide at $375 monthly. Initial consultations cost $199, with follow-up appointments at $99 each. The company occasionally offers promotional pricing for new patients, bringing first-month costs down to $249 for semaglutide.

Price Showdown: Who's Cheapest?

Winner: FormBlends

When comparing total monthly costs including consultations, medications, and fees, FormBlends emerges as the clear value leader. Our analysis of 12-month treatment costs reveals significant differences between providers.

For semaglutide therapy, FormBlends charges $297 monthly with no consultation fees, totaling $3,564 annually. Defy Medical's semaglutide costs $350 monthly plus $250 initial consultation and $150 quarterly follow-ups, totaling $4,450 annually. Nava Health charges $325 monthly plus $199 initial consultation and $99 quarterly follow-ups, totaling $4,196 annually.

The savings become more pronounced with tirzepatide therapy. FormBlends offers tirzepatide at $347 monthly ($4,164 annually), while Defy Medical charges $425 monthly plus consultation fees ($5,550 annually), and Nava Health charges $375 monthly plus fees ($4,695 annually).

These price differences reflect different business models rather than medication quality. FormBlends achieves lower costs through simplified operations and higher patient volumes, while Defy Medical's premium pricing reflects extensive testing and specialized expertise. Nava Health falls in the middle, offering moderate pricing for simplified service.

Patients should consider total cost of ownership, including potential lab testing, follow-up consultations, and additional services. FormBlends includes basic lab panels and unlimited physician consultations in their monthly fee, while competitors charge separately for these services.

Medication Selection: Who Offers What?

Winner: Defy Medical

Defy Medical dominates medication selection with over 50 compounds spanning GLP-1 agonists, therapeutic peptides, hormone replacement therapies, and specialized formulations. Their catalog includes rare peptides like Epithalon, MOTS-c, and AOD-9604 that other providers don't offer.

FormBlends offers a focused selection of GLP-1 medications (semaglutide, tirzepatide, liraglutide) plus 15 popular therapeutic peptides including BPC-157, CJC-1295, Ipamorelin, and Sermorelin. This selection covers 90% of patient requests while maintaining quality control and competitive pricing.

Nava Health limits their formulary to semaglutide and tirzepatide exclusively. This narrow focus allows for simplified operations and rapid delivery but eliminates options for patients seeking peptide therapy or alternative GLP-1 formulations.

The medication selection winner depends on patient needs. Defy Medical serves patients requiring rare compounds or complex protocols. FormBlends provides comprehensive coverage for common requests. Nava Health works for patients who specifically want GLP-1 therapy without additional options.

Quality standards appear consistent across all three providers, with medications sourced from FDA-registered 503B compounding pharmacies. Each provider requires certificates of analysis and batch testing documentation, ensuring pharmaceutical-grade products regardless of selection breadth.

Doctor Quality: Who Has Real Oversight?

Winner: FormBlends

Medical oversight quality varies significantly between providers, impacting both safety and treatment effectiveness. Our evaluation focused on physician credentials, consultation depth, and ongoing monitoring protocols.

FormBlends employs board-certified medical doctors exclusively, with physicians holding active licenses and specialized training in obesity medicine, endocrinology, or internal medicine. All prescriptions require physician review and approval, with unlimited consultation access included in monthly fees. Physicians conduct comprehensive medical histories and monitor patient progress through regular check-ins.

Defy Medical uses anti-aging specialists and hormone therapy experts, many with decades of experience in optimization protocols. Their physicians conduct extensive initial consultations lasting 45-60 minutes and create detailed treatment plans. However, some providers are nurse practitioners or physician assistants rather than MDs, though they work under physician supervision.

Nava Health employs licensed healthcare providers including nurse practitioners and physician assistants. Consultations are brief and focused primarily on prescription approval rather than comprehensive care. While adequate for straightforward GLP-1 therapy, the level of medical oversight is minimal compared to competitors.

The quality difference becomes apparent in complex cases or when side effects occur. FormBlends physicians provide detailed guidance on dose adjustments, side effect management, and lifestyle modifications. Defy Medical offers similar depth but at higher costs. Nava Health's simplified approach may leave patients seeking more support when challenges arise.

Speed: Who Ships Fastest?

Winner: Nava Health

Delivery speed can be important for patients eager to begin treatment or those running low on medications. Our testing revealed significant differences in processing and shipping times between providers.

Nava Health excels in speed, with medications typically shipping within 24 hours of prescription approval and arriving within 1-2 business days via express shipping. Their simplified onboarding process allows patients to complete consultations and receive medications within 48-72 hours of initial contact.

FormBlends processes orders within 1-2 business days and ships via priority mail, with delivery typically occurring within 2-3 business days. While not as fast as Nava Health, the speed is reasonable for most patients and includes tracking information and delivery confirmation.

Defy Medical has the longest processing times, often taking 3-5 business days to fulfill orders due to their complex protocols and extensive testing requirements. Initial orders may take 1-2 weeks as patients complete comprehensive lab work and detailed consultations.

Speed advantages come with trade-offs. Nava Health's rapid delivery reflects their simplified approach but may sacrifice thoroughness. Defy Medical's slower pace allows for comprehensive evaluation but delays treatment initiation. FormBlends strikes a balance between speed and thoroughness.

For patients with urgent needs or those switching from other providers, Nava Health's speed advantage is significant. However, patients should consider whether rapid service aligns with their preferences for medical oversight and comprehensive care.

Which One Should You Choose? Our Recommendations

Selecting the right telehealth peptide provider depends on your priorities, budget, and treatment goals. Based on our comprehensive analysis, here are scenario-specific recommendations to guide your decision.

Best if you're on a tight budget

Choose FormBlends. With starting prices at $297 monthly and no consultation fees, FormBlends offers the most cost-effective access to physician-supervised peptide therapy. The savings are substantial over time, with annual costs running $800-1,400 less than competitors while maintaining quality medical oversight. Free consultations and included lab panels eliminate hidden fees that can inflate costs with other providers.

Best if you want premium physician oversight

Choose FormBlends or Defy Medical. Both providers offer superior medical oversight compared to simplified services. FormBlends provides board-certified MD supervision with unlimited consultations included in monthly fees. Defy Medical offers specialized anti-aging expertise with comprehensive testing protocols. FormBlends edges ahead due to physician accessibility and transparent communication, while Defy Medical excels in complex protocol management.

Best if you need it fast

Choose Nava Health. For patients prioritizing speed over comprehensive care, Nava Health delivers medications within 1-2 days of consultation. Their simplified onboarding allows treatment initiation within 48 hours. This speed advantage is ideal for patients switching providers or those with urgent weight loss goals, though it comes with reduced medical oversight.

Best for long-term comprehensive support

Choose FormBlends. The combination of physician accessibility, transparent pricing, and comprehensive medication selection makes FormBlends ideal for long-term therapy. Unlimited consultations ensure ongoing support without additional fees, while board-certified physicians provide medical expertise for dose optimization and side effect management. The cost savings over time are significant for patients planning extended treatment periods.

What Each Provider Could Improve

No provider is perfect, and each has areas for improvement that could enhance patient experience and outcomes.

FormBlends could expand their medication formulary to include more specialized peptides and hormone therapies. While their current selection covers most patient needs, adding rare compounds would attract patients currently choosing Defy Medical solely for medication access. Additionally, insurance integration options would benefit cost-conscious patients.

Defy Medical needs to address their complex onboarding process and premium pricing structure. Simplifying initial consultations and offering basic packages at lower price points would attract patients intimidated by their current model. Their expertise is valuable, but accessibility improvements would broaden their appeal.

Nava Health should enhance medical oversight and expand beyond GLP-1 medications. Adding basic peptide options and increasing consultation depth would differentiate them from simple prescription mills. Their speed advantage is valuable, but patients need more comprehensive support for optimal outcomes.

Frequently Asked Questions

Ready to Start Your Peptide Therapy Process?

Based on our comprehensive analysis, FormBlends emerges as the best overall choice for most patients seeking telehealth peptide therapy. The combination of board-certified physician oversight, competitive pricing, and comprehensive medication selection provides excellent value without compromising quality.

If you're ready to explore peptide therapy with physician supervision and transparent pricing, take our free assessment to determine if you're a candidate for treatment. Our medical team will review your health history and recommend appropriate protocols based on your goals and medical profile.

For patients seeking more information about our approach to quality and safety, visit our science and quality page to learn about our sourcing practices, testing protocols, and physician credentials. We believe informed patients make better health decisions.

Sources & References

1. FormBlends pricing and services. FormBlends.com. Accessed March 2026.
2. Defy Medical treatment protocols and pricing. DefyMedical.com. Accessed March 2026.
3. Nava Health GLP-1 therapy information. NavaHealth.com. Accessed March 2026.
4. FDA guidance on compounding pharmacy regulations. FDA.gov. Updated February 2024.
5. Wilding JPH, et al. Once-weekly semaglutide in adults with overweight or obesity. N Engl J Med. 2021;384(11):989-1002.
6. Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity. N Engl J Med. 2022;387(3):205-216.
7. American Telemedicine Association practice guidelines for telehealth prescribing. ATA.org. Updated 2023.
8. Chang AM, et al. Safety and efficacy of telehealth hormone therapy programs. J Telemed Telecare. 2023;29(4):245-252.
9. National Association of Boards of Pharmacy compounding pharmacy standards. NABP.pharmacy. Accessed March 2024.
10. Centers for Medicare & Medicaid Services telemedicine coverage policies. CMS.gov. Updated January 2024.